COLL
Collegium Pharmaceutical, Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Collegium Pharmaceutical, Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report3 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−18.55%
vs ±12.2% implied · ×1.52
shaded = implied · ▲▼ = realized
Collegium Pharmaceutical, Inc
23.77
−0.26 · −1.06%
post 23.78 +0.02%
No thesis.
Largest filed tie
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $197.0M | 13.88% | +5.98% | |
| 2 | Jupiter TopcoJupiter Topco | $77.7M | 5.48% | — | |
| 3 | InvescoInvesco | $68.1M | 4.80% | +18.25% | |
| 4 | Fuller & Thaler Asset ManagementFuller & Thaler | $59.1M | 4.16% | +8.88% | |
| 5 | Principal Financial GroupPrincipal Financial | $59.1M | 4.16% | +26.05% | |
| 6 | State StreetState Streetindex-like | $55.3M | 3.90% | +7.32% | |
| 7 | Massachusetts Financial ServicesMassachusetts Financial Services | $50.9M | 3.58% | +2.90% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $50.0M | 3.52% | +3.54% | |
| 9 | Renaissance TechnologiesRenaissance Technologies | $49.5M | 3.48% | −7.00% | |
| 10 | Eventide Asset ManagementEventide | $49.3M | 3.47% | −4.43% | |
| 11 | Rubric Capital ManagementRubric | $46.3M | 3.26% | 0.00% | |
| 12 | Geode Capital ManagementGeodeindex-like | $32.3M | 2.27% | +8.72% | |
| 13 | Dimensional Fund AdvisorsDimensional | $30.3M | 2.14% | +0.56% | |
| 14 | Victory Capital ManagementVictory | $27.5M | 1.94% | +21.58% | |
| 15 | Goldentree Asset ManagementGoldentree | $26.9M | 1.90% | new | |
| 16 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $26.8M | 1.89% | +8.77% | |
| 17 | Millennium ManagementMillennium | $26.7M | 1.88% | +104.23% | |
| 18 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $22.5M | 1.59% | −11.60% | |
| 19 | Goldman Sachs GroupGoldman Sachs | $20.2M | 1.42% | −3.17% | |
| 20 | Morgan StanleyMorgan Stanley | $19.4M | 1.36% | +3.80% | |
| 21 | American Century CompaniesAmerican Century Companies | $17.8M | 1.25% | +6.70% | |
| 22 | Charles Schwab Investment ManagementCharles Schwabindex-like | $17.6M | 1.24% | −1.70% | |
| 23 | Qube Research & TechnologiesQube Research & Technologies | $15.6M | 1.10% | −30.63% | |
| 24 | Northern TrustNorthern Trustindex-like | $14.2M | 1.00% | +8.26% | |
| 25 | Loomis Sayles & Co L PLoomis Sayles & Co L P | $13.2M | 0.93% | −2.84% |
278 managers report $1.4B of Collegium Pharmaceutical on form 13F for the quarter ended Jun 30 '26. 31 of them hold 80% of it; BlackRock is largest at 13.88%.
No implied move.
No implied move.
Expected move
No implied move.